UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 126

Sortiert nach

Malignant Transformation of Giant Cell Tumor of Bone and the Association with Denosumab Treatment: A Radiology and Pathology Perspective

Sarcoma, 2022-06, Vol.2022, p.1-11

2022

Link zum Volltext

Verfügbarkeit prüfen

Increased Prevalence of Malignancies in Fibrous Dysplasia/McCune-Albright Syndrome (FD/MAS): Data from a National Referral Center and the Dutch National Pathology Registry (PALGA)

Calcified tissue international, 2021-03, Vol.108 (3), p.346-353

2021

Link zum Volltext

Verfügbarkeit prüfen

Targeting survivin as a potential new treatment for chondrosarcoma of bone

Oncogenesis (New York, NY), 2016-05, Vol.5 (5), p.e222-e222

2016

Link zum Volltext

Verfügbarkeit prüfen

Presacral myelolipoma, case report and literature review

Annals of medicine and surgery, 2020-09, Vol.57, p.274-280

2020

Link zum Volltext

Verfügbarkeit prüfen

Poorer outcome in stromal HIF-2 alpha- and CA9-positive colorectal adenocarcinomas is associated with wild-type TP53 but not with BNIP3 promoter hypermethylation or apoptosis

British journal of cancer, 2008-09, Vol.99 (5), p.727-733

2008

Link zum Volltext

Verfügbarkeit prüfen

MOLECULAR ANALYSIS OF PRIMARY CUTANEOUS DIFFUSE LARGE B-CELL LYMPHOMA LEG TYPE AT DIAGNOSIS AND RELAPSE - IMPLICATIONS FOR TARGETED THERAPIES: PF509

HemaSphere, 2019-06, Vol.3, p.207-208

2019

Link zum Volltext

Verfügbarkeit prüfen

Poorer outcome in stromal HIF-2[alpha]- and CA9-positive colorectal adenocarcinomas is associated with wild-type TP53 but not with BNIP3 promoter hypermethylation or apoptosis

British journal of cancer, 2008-09, Vol.99 (5), p.727

2008

Link zum Volltext

Verfügbarkeit prüfen

Poorer outcome in stromal HIF-2a-and CA9-positive colorectal adenocarcinomas is associated with wild-type TP53 but not with BNIP3 promoter hypermethylation or apoptosis

British journal of cancer, 2008, Vol.99 (5), p.727-733

2008

Link zum Volltext

Verfügbarkeit prüfen

Presacral myelolipoma, case report and literature review

Annals of medicine and surgery (2012), 2020, Vol.57, p.274-280

2020

Link zum Volltext

Verfügbarkeit prüfen

Mutation Analysis of H3F3A and H3F3B as a Diagnostic Tool for Giant Cell Tumor of Bone and Chondroblastoma

The American journal of surgical pathology, 2015-11, Vol.39 (11), p.1576-1583

2015

Link zum Volltext

Verfügbarkeit prüfen

Increased PD-L1 and T-cell infiltration in the presence of HLA class I expression in metastatic high-grade osteosarcoma: a rationale for T-cell-based immunotherapy

Cancer Immunology, Immunotherapy, 2017-01, Vol.66 (1), p.119-128

2017

Link zum Volltext

Verfügbarkeit prüfen

Utility of FOS as diagnostic marker for osteoid osteoma and osteoblastoma

Virchows Archiv : an international journal of pathology, 2020-03, Vol.476 (3), p.455-463

2020

Link zum Volltext

Verfügbarkeit prüfen

Molecular Analysis of Gene Fusions in Bone and Soft Tissue Tumors by Anchored Multiplex PCR–Based Targeted Next-Generation Sequencing

The Journal of molecular diagnostics : JMD, 2018-09, Vol.20 (5), p.653-663

2018

Link zum Volltext

Verfügbarkeit prüfen

Loss of H3K27 tri-methylation is a diagnostic marker for malignant peripheral nerve sheath tumors and an indicator for an inferior survival

Modern pathology, 2016-06, Vol.29 (6), p.582-590

2016

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and Toxicity of Calcitonin Treatment in Children with Cherubism: A Single‐Center Cohort Study

Journal of bone and mineral research, 2023-12, Vol.38 (12), p.1822-1833

2023

Link zum Volltext

Verfügbarkeit prüfen

Oestrogen receptor expression distinguishes non-ossifying fibroma from other giant cell containing bone tumours

Virchows Archiv : an international journal of pathology, 2022-10, Vol.481 (4), p.671-675

2022

Link zum Volltext

Verfügbarkeit prüfen

RANKL inhibition for giant cell lesions of the jaw: A retrospective cohort analysis

European journal of cancer (1990), 2022-11, Vol.175, p.263-273

2022

Link zum Volltext

Verfügbarkeit prüfen

Clinical, Histologic, and Molecular Characteristics of Anaplastic Lymphoma Kinase-positive Primary Cutaneous Anaplastic Large Cell Lymphoma

The American journal of surgical pathology, 2020-06, Vol.44 (6), p.776

2020

Link zum Volltext

Verfügbarkeit prüfen

Molecular findings in maxillofacial bone tumours and its diagnostic value

Virchows Archiv : an international journal of pathology, 2020-01, Vol.476 (1), p.159-174

2020

Link zum Volltext

Verfügbarkeit prüfen

Prognostic Metabolite Biomarkers for Soft Tissue Sarcomas Discovered by Mass Spectrometry Imaging

Journal of the American Society for Mass Spectrometry, 2017-02, Vol.28 (2), p.376-383

2017

Link zum Volltext

Verfügbarkeit prüfen

Emerging evidence for CHFR as a cancer biomarker: from tumor biology to precision medicine

Cancer and metastasis reviews, 2014-03, Vol.33 (1), p.161-171

2014

Link zum Volltext

Verfügbarkeit prüfen

Analysis of PD-L1, T-cell infiltrate and HLA expression in chondrosarcoma indicates potential for response to immunotherapy specifically in the dedifferentiated subtype

Modern pathology, 2016-09, Vol.29 (9), p.1028-1037

2016

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 126

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(111)
Mit Volltextzugriff
(119)

Publikationsform

Artikel
(123)
Berichte
(3)

Sprache

Englisch
(125)
Japanisch
(16)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Malignant Transformation of Giant Cell Tumor of Bone and the Association with Denosumab Treatment: A Radiology and Pathology Perspective

Increased Prevalence of Malignancies in Fibrous Dysplasia/McCune-Albright Syndrome (FD/MAS): Data from a National Referral Center and the Dutch National Pathology Registry (PALGA)

Targeting survivin as a potential new treatment for chondrosarcoma of bone

Presacral myelolipoma, case report and literature review

Poorer outcome in stromal HIF-2 alpha- and CA9-positive colorectal adenocarcinomas is associated with wild-type TP53 but not with BNIP3 promoter hypermethylation or apoptosis

MOLECULAR ANALYSIS OF PRIMARY CUTANEOUS DIFFUSE LARGE B-CELL LYMPHOMA LEG TYPE AT DIAGNOSIS AND RELAPSE - IMPLICATIONS FOR TARGETED THERAPIES: PF509

Poorer outcome in stromal HIF-2[alpha]- and CA9-positive colorectal adenocarcinomas is associated with wild-type TP53 but not with BNIP3 promoter hypermethylation or apoptosis

Poorer outcome in stromal HIF-2a-and CA9-positive colorectal adenocarcinomas is associated with wild-type TP53 but not with BNIP3 promoter hypermethylation or apoptosis

Presacral myelolipoma, case report and literature review

Mutation Analysis of H3F3A and H3F3B as a Diagnostic Tool for Giant Cell Tumor of Bone and Chondroblastoma

Increased PD-L1 and T-cell infiltration in the presence of HLA class I expression in metastatic high-grade osteosarcoma: a rationale for T-cell-based immunotherapy

Utility of FOS as diagnostic marker for osteoid osteoma and osteoblastoma

Molecular Analysis of Gene Fusions in Bone and Soft Tissue Tumors by Anchored Multiplex PCR–Based Targeted Next-Generation Sequencing

A subset of epithelioid and spindle cell rhabdomyosarcomas is associated with TFCP2 fusions and common ALK upregulation

Loss of H3K27 tri-methylation is a diagnostic marker for malignant peripheral nerve sheath tumors and an indicator for an inferior survival

Efficacy and Toxicity of Calcitonin Treatment in Children with Cherubism: A Single‐Center Cohort Study

Oestrogen receptor expression distinguishes non-ossifying fibroma from other giant cell containing bone tumours

RANKL inhibition for giant cell lesions of the jaw: A retrospective cohort analysis

Clinical, Histologic, and Molecular Characteristics of Anaplastic Lymphoma Kinase-positive Primary Cutaneous Anaplastic Large Cell Lymphoma

High prevalence of MYD88 and CD79B mutations in intravascular large B-cell lymphoma

Molecular findings in maxillofacial bone tumours and its diagnostic value

Prognostic Metabolite Biomarkers for Soft Tissue Sarcomas Discovered by Mass Spectrometry Imaging

Emerging evidence for CHFR as a cancer biomarker: from tumor biology to precision medicine

Genetic Stability of Driver Alterations in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type and Their Relapses: A Rationale for the Use of Molecular-Based Methods for More Effective Disease Monitoring

Analysis of PD-L1, T-cell infiltrate and HLA expression in chondrosarcoma indicates potential for response to immunotherapy specifically in the dedifferentiated subtype

Suchergebnisse filtern